Skip to main content

Use of atypical antipsychotic drugs in old age psychiatry

  • Walter Pierre Bouman and Gill Pinner

Antipsychotic drugs are among the most widely prescribed psychotropic medications for elderly people, particularly for the 5–8% of patients who are in institutions. The antipsychotics are indicated for treating psychotic disorders, including schizophrenia, delusional disorder, psychotic symptoms in mood disorders and for a number of organic psychoses.

Hide All
Avorn, J., Monane, M., Everitt, D. E. et al (1994) Clinical assessment of extrapyramidal signs in nursing home patients given antipsychotic medication. Archives of Internal Medicine, 154, 11131117.
Ballard, C., Bannister, C., Graham, C. et al (1995) Associations of psychotic symptoms in dementia sufferers. British Journal of Psychiatry, 167, 537540.
Beasley, C.M., Tollefson, G. D. & Tran, P. V. (1997) Efficacy of olanzapine: an overview of pivotal clinical trials. Journal of Clinical Psychiatry, 58 (suppl. 10), 712.
Bhana, N. & Spencer, C. M. (2000) Risperidone – a review of its use in the management of the behavioural and psychological symptoms of dementia. Drugs and Aging, 16, 451471.
Byerly, M. J., Weber, M. T., Brooks, D. L. et al (2001) Antipsychotic medications and the elderly: effects on cognition and implications for use. Drugs and Aging, 18, 4561.
Chengappa, K. N. R., Baker, R. W., Kreinbrook, S. B. et al (1995) Clozapine use in female geriatric patients with psychosis. Journal of Geriatric Psychiatry and Neurology, 8, 1215.
Committee on Safety of Medicines – Medicines Control Agency (1995) Cardiac arrhythmias with pimozide (Orap). Current Problems in Pharmacovigilance, 21, 1.
Committee on Safety of Medicines – Medicines Control Agency (1999) Suspension of availability of sertindol (Serdolect). Current Problems in Pharmacovigilance, 25, 1.
De Deyn, P. P. & Katz, I. R. (2000) Control of aggression and agitation in patients with dementia: efficacy and safety of risperidone. International Journal of Geriatric Psychiatry, 15, S14S22.
De Deyn, P. P., Rabheru, K., Rasmussen, A. et al (1999) A randomised trial of risperidone, placebo, and haloperidol for behavioural symptoms of dementia. Neurology, 53, 946955.
Dewey, R. B. & O'Suilleabhain, P. E. (2000) Treatment of drug-induced psychosis with quetiapine and clozapine in Parkinson's disease. Neurology, 55, 1753.
Folstein, M. F., Folstein, S. E. & McHugh, P. R. (1975) ‘Mini-Mental State’: a practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189198.
Goetz, C. G., Blasucci, L. M. & Leurgan, S. (2000) Olanzapine and clozapine: comparative effects on motor function in hallucinating PD patients. Neurology, 55, 789794.
Howanitz, E., Pardo, M., Smelson, D.A. et al (1999) The efficacy and safety of clozapine versus chlorpromazine in geriatric schizophrenia. Journal of Clinical Psychiatry, 60, 4144.
Jeste, D. V., Caligiuri, M. P., Paulsen, J. S. et al (1995) Risk of tardive dyskinesia in older patients: a prospective longitudinal study of 266 outpatients. Archives of General Psychiatry, 52, 756765.
Jeste, D. V., Okamoto, A., Napolitano, J. et al (2000) Low incidence of tardive dyskinesia in elderly patients with dementia treated with risperidone. American Journal of Psychiatry, 157, 11501155.
Katz, I. R., Jeste, D. V., Mintzer, J. E. et al (1999) Comparison of risperidone and placebo for psychological and behavioural disturbances associated with dementia: a randomised double blind trial. Journal of Clinical Psychiatry, 60, 107115.
Kelly, H. G., Fay, J. E. & Laverty, S. G. (1963) Thioridazine hydrochloride (Melleril): its effect on the electrocardiogram and a report of two fatalities with electrocardiographic abnormalities. Journal of the Canadian Medical Association, 89, 546554.
Lanctot, K. L., Best, T. S., Mittmann, N. et al (1998) Efficacy and safety of neuroleptics in behavioural disorders associated with dementia. Journal of Clinical Psychiatry, 59, 550561.
Madhusoodanan, S., Brenner, R., Suresh, P. et al (2000) Efficacy and tolerability in elderly patients with psychotic disorders: a prospective study. Annals of Clinical Psychiatry, 12, 1118.
Maixner, S. M., Mellow, A. M. & Tandon, R. (1999) The efficacy, safety and tolerability of antipsychotics in the elderly. Journal of Clinical Psychiatry, 60 (suppl. 8), 2941.
McManus, D. Q., Arvanitis, L. A. & Kowalcyk, B. B. (1999) Quetiapine, a novel antipsychotic: experience in elderly patients with psychotic disorders. Journal of Clinical Psychiatry, 60, 292298.
McShane, R., Keene, J., Gedling, K. et al (1997) Do neuroleptic drugs hasten cognitive decline in dementia? Prospective study with necropsy follow up. BMJ, 314, 266270.
OHRMS (2001) Clinically Important QT Interval Prolongation with Three Antipsychotics. Pfizer Study 054. Bethesda, MD: Food and Drug Adminstration (
Overall, J. E. & Gorham, D. R. (1962) The Brief Psychiatric Rating Scale. Psychological Reports, 10, 799812.
Reilly, J. G., Ayis, S. A., Ferrier, I. N. et al (2000) QTc-interval abnormalities and psychotropic drug therapy in psychiatric patients. Lancet, 355, 10481052.
Reisberg, B., Borenstein, J., Salob, S. P. et al (1987) Behave– AD. Journal of Clinical Psychiatry, 48 (suppl.), 915.
Sajatovic, M., Jaskiw, G., Konicki, P. E. et al (1997) Outcome of clozapine therapy for elderly patients with refractory primary psychosis. International Journal of Geriatric Psychiatry, 12, 553558.
Sajatovic, M., Ramirez, L. F., Garver, D. et al (1998a) Clozapine therapy for older veterans. Psychiatric Services, 49, 340344.
Sajatovic, M., Perez, D., Brescan, D. et al (1998b) Olanzapine therapy in elderly patients with schizophrenia. Psychopharmacology Bulletin, 34, 819823.
Satterlee, W. G., Reams, S. G., Burns, P. R. et al (1995) A clinical update on olanzapine treatment in schizophrenia and in elderly Alzheimer's disease patients (abstract). Psychopharmacology Bulletin, 31, 534.
Schneider, L. S., Pollock, V. E. & Lyness, S. A. (1990) A meta-analysis of controlled trials of neuroleptic treatment in dementia. Journal of the American Geriatrics Society, 38, 553563.
Schneider, L., Yeung, P., Sweitzer, D. et al (1999) Quetiapine may reduce hostility in patients with psychoses related to Alzheimer's disease. Schizophrenia Research, 36, 295296.
Street, J. S., Clark, W. S., Gannon, K. S. et al (2000) Olanzapine treatment of psychotic and behavioral symptoms in patients with alzheimer disease in nursing care facilities. Archives of General Psychiatry, 57, 968976.
Sweet, R. A. & Pollock, B. G. (1998) New atypical antipsychotics. Drugs and Aging, 12, 115127.
Tariot, P. N., Salzman, C., Yeung, P. P. et al (2000) Long-term use of quetiapine in elderly patients with psychotic disorders. Clinical Therapeutics, 22, 10681084.
Parkinson Study Group (1999) Low-dose clozapine for the treatment of drug-induced psychosis in Parkinson's disease. New England Journal of Medicine, 340, 757763.
Verhaeverbeke, I. & Mets, T. (1997) Drug-induced orthostatic hypotension in the elderly: avoiding its onset. Drug Safety, 17, 105118.
Wahlbeck, K., Cheine, M., Essali, A. et al (1999) Evidence of clozapine's effectiveness in schizophrenia: a systematic review and meta-analysis of randomised trials. American Journal of Psychiatry, 156, 990999.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

BJPsych Advances
  • ISSN: 1355-5146
  • EISSN: 1472-1481
  • URL: /core/journals/bjpsych-advances
Please enter your name
Please enter a valid email address
Who would you like to send this to? *


Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed

Use of atypical antipsychotic drugs in old age psychiatry

  • Walter Pierre Bouman and Gill Pinner
Submit a response


No eLetters have been published for this article.


Reply to: Submit a response

Your details

Conflicting interests

Do you have any conflicting interests? *